Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where P. Brochard is active.

Publication


Featured researches published by P. Brochard.


Occupational and Environmental Medicine | 2006

The French National Mesothelioma Surveillance Program

M. Goldberg; E. Imbernon; P. Rolland; A. Gilg Soit Ilg; M Savès; A. De Quillacq; C. Frenay; Soizick Chamming's; P Arveux; C Boutin; Guy Launoy; J.-C. Pairon; Philippe Astoul; Françoise Galateau-Sallé; P. Brochard

Objectives: The French National Mesothelioma Surveillance Program (NMSP) was established in 1998 by the National Institute for Health Surveillance (InVS). Its objectives are to estimate the trends in mesothelioma incidence and the proportion attributable to occupational asbestos exposure, to help improve its pathology diagnosis, to assess its compensation as an occupational disease, and to contribute to research. Methods: The NMSP records incident pleural tumours in 21 French districts that cover a population of approximately 16 million people (a quarter of the French population). A standardised procedure of pathological and clinical diagnosis ascertainment is used. Lifetime exposure to asbestos and to other factors (man made mineral fibres, ionising radiation, SV40 virus) is reconstructed, and a case-control study was also conducted. The proportion of mesothelioma compensated as an occupational disease was assessed. Results: Depending on the hypothesis, the estimated number of incident cases in 1998 ranged from 660 to 761 (women: 127 to 146; men: 533 to 615). Among men, the industries with the highest risks of mesothelioma are construction and ship repair, asbestos industry, and manufacture of metal construction materials; the occupations at highest risk are plumbers, pipe-fitters, and sheet-metal workers. The attributable risk fraction for occupational asbestos exposure in men was 83.2% (95% CI 76.8 to 89.6). The initial pathologist’s diagnosis was confirmed in 67% of cases, ruled out in 13%, and left uncertain in the others; for half of the latter, the clinical findings supported a mesothelioma diagnosis. In all, 62% applied for designation of an occupational disease, and 91% of these were receiving workers’ compensation. Conclusions: The NMSP is a large scale epidemiological surveillance system with several original aspects, providing important information to improve the knowledge of malignant pleural mesothelioma, such as monitoring the evolution of its incidence, of high risk occupations and economic sectors, and improving pathology techniques.


Annales De Pathologie | 2014

Mésothéliome : les dispositifs en place en France « le réseau mésothéliome » 1998–2013

Françoise Galateau-Sallé; A. Gilg Soit Ilg; N. Le Stang; P. Brochard; Jean-Claude Pairon; Philippe Astoul; C. Frenay; G. Blaizot; S. Chamming's; S. Ducamp; T. Rousvoal; A. De Quillacq; V. Abonnet; Issam Abd-Alsamad; Hugues Begueret; Elizabeth Brambilla; Frédérique Capron; Marie-Christine Copin; Claire Danel; A.Y. de Lajartre; A. Foulet-Roge; L. Garbe; Odile Groussard; S. Giusiano; Véronique Hofman; Sylvie Lantuejoul; J.M. Piquenot; Isabelle Rouquette; Christine Sagan; Françoise Thivolet-Béjui

Mesothelioma is a rare disease less than 0.3% of cancers in France, very aggressive and resistant to the majority of conventional therapies. Asbestos exposure is nearly the only recognized cause of mesothelioma in men observed in 80% of case. In 1990, the projections based on mortality predicted a raise of incidence in mesothelioma for the next three decades. Nowadays, the diagnosis of this cancer is based on pathology, but the histological presentation frequently heterogeneous, is responsible for numerous pitfalls and major problems of early detection toward effective therapy. Facing such a diagnostic, epidemiological and medico-legal context, a national and international multidisciplinary network has been progressively set up in order to answer to epidemiological survey, translational or academic research questions. Moreover, in response to the action of the French Cancer Program (action 23.1) a network of pathologists was organized for expert pathological second opinion using a standardized procedure of certification for mesothelioma diagnosis. We describe the network organization and show the results during this last 15years period of time from 1998-2013. These results show the major impact on patients management, and confirm the interest of this second opinion to provide accuracy of epidemiological data, quality of medico-legal acknowledgement and accuracy of clinical diagnostic for the benefit of patients. We also show the impact of these collaborative efforts for creating a high quality clinicobiological, epidemiological and therapeutic data collection for improvement of the knowledge of this dramatic disease.


Revue des Maladies Respiratoires Actualités | 2010

Apports de l’analyse minéralogique en pratique clinique

P. Brochard; M. Vincent; Jean-Claude Pairon; Pascal Dumortier; P. De Vuyst; T. Gille

Resume L’inhalation de particules minerales peut provoquer une grande variete d’affections pulmonaires. L’identification d’une retention de ces particules par l’analyse mineralogique, suivant des recommandations techniques rappelees dans ce texte, peut etre un outil diagnostique indispensable et permettre l’ouverture de droits au travailleur expose. Parce qu’elles peuvent etre causees par des expositions cumulees relativement faibles, les atteintes pleurales benignes et le mesotheliome dominent la pathologie asbestosique, tandis que le nombre de cancers broncho-pulmonaires lies a l’amiante semble sous-estime et que l’asbestose est devenue rare dans les pays developpes, tout comme les autres pneumoconioses.


American Journal of Industrial Medicine | 2012

Choice of rating method for assessing occupational asbestos exposure: study for compensation purposes in France.

C. Gramond; Patrick Rolland; Aude Lacourt; S. Ducamp; Soizick Chamming's; Yvon Creau; M. Hery; Jacques Laureillard; Brahim Mohammed-Brahim; Ewa Orlowski; Christophe Paris; Jean-Claude Pairon; M. Goldberg; P. Brochard


American Journal of Industrial Medicine | 2013

Compensation of pleural mesothelioma in France: Data from the French National Mesothelioma Surveillance Programme

Soizick Chamming's; Bénédicte Clin; P. Brochard; Philippe Astoul; S. Ducamp; Fançoise Galateau‐Salle; Annabelle Gilg Soit Ilg; M. Goldberg; C. Gramond; Ellen Imbernon; Patrick Rolland; J.-C. Pairon


Lung Cancer | 2006

35 Risk of pleural mesothelioma: A French population-based case-control study (1998-2002)

P. Rolland; S. Ducamp; C. Gramond; Françoise Galateau-Sallé; J.-C. Pairon; Philippe Astoul; Soizick Chamming's; A. Gilg Soit Ilg; E. Imbernon; M. Goldberg; P. Brochard


Safety Science | 2014

A comparison of three methods to identify chemicals hazards in French research laboratories

Fanny Bourrée; Louis Rachid Salmi; Alain Garrigou; Sandrine Domecq; P. Brochard; Philippe Michel


/data/revues/03987620/0050SUP4/1S56/ | 2008

C7-1 - Estimation de l'incidence du mésothéliome en France à partir des données du Programme National de Surveillance du Mésothéliome

A Gilg Soit Ilg; Guy Launoy; F Galateau; Philippe Astoul; P. Brochard; J.-C. Pairon; E. Imbernon; M. Goldberg


Occupational and Environmental Medicine | 2007

Surveillance and health care

A. G. Kraut; K. M. Venables; S. Allender; R. McNamee; M. Carder; Y. Chen; R. Agius; A.G.S. Ilg; E. Imbernon; P. Rolland; S. Ducamp; A. De Quillacq; C. Frenay; Soizick Chamming's; Guy Launoy; J.-C. Pairon; Philippe Astoul; Françoise Galateau-Sallé; P. Brochard; M. Goldberg; B. Geoffroy-Perez; S. Julliard; A. Fouquet; S. H. Lo; J. D. Wang; C. S. Liau; A. Carosi; N. Lightfoot; K. Alkema; T. R. Driscoll


Lung Cancer | 2006

236 Prolonged survival in malignant mesothelioma: A study of nineteen cases

Françoise Galateau-Sallé; P. Vergani; Philippe Astoul; P. Rolland; J.-C. Pairon; P. Brochard; M. Matrat; V. Abonnet; E. Imbernon; A. Gilg Soit Ilg; M. Goldberg; Guy Launoy

Collaboration


Dive into the P. Brochard's collaboration.

Top Co-Authors

Avatar

M. Goldberg

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

S. Ducamp

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

C. Frenay

Aix-Marseille University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C. Gramond

Université Bordeaux Segalen

View shared research outputs
Top Co-Authors

Avatar

A. Gilg Soit Ilg

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

Patrick Rolland

Institut de veille sanitaire

View shared research outputs
Top Co-Authors

Avatar

Alain Garrigou

Université Bordeaux Segalen

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge